{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:07:37Z","timestamp":1778803657504,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jiac.2026.102965","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:33:28Z","timestamp":1776285208000},"page":"102965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to anti-Tuberculosis treatment during the COVID-19 pandemic: a single-centre, retrospective analysis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9179-8698","authenticated-orcid":false,"given":"Filippo","family":"Ducci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Enrico","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Lagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bresci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-7094","authenticated-orcid":false,"given":"Jessica","family":"Mencarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102965_bib1","series-title":"Global tuberculosis report 2025","year":"2025"},{"key":"10.1016\/j.jiac.2026.102965_bib2","series-title":"Tuberculosis surveillance and monitoring in Europe 2025 \u2013 2023 data","year":"2025"},{"key":"10.1016\/j.jiac.2026.102965_bib3","unstructured":"Who, \u2018WHO consolidated guidelines on tuberculosis. Module 4: treatment and care\u2019."},{"key":"10.1016\/j.jiac.2026.102965_bib4","series-title":"Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis', Oct. 01","author":"Nahid","year":"2016"},{"issue":"7","key":"10.1016\/j.jiac.2026.102965_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2026.102965_bib6","series-title":"How do we measure adherence to anti-tuberculosis treatment?","author":"Valencia","year":"2017"},{"key":"10.1016\/j.jiac.2026.102965_bib7","series-title":"The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions","author":"Dheda","year":"2022"},{"key":"10.1016\/j.jiac.2026.102965_bib8","series-title":"A systematic literature review comparing methods for the measurement of patient persistence and adherence","author":"Forbes","year":"2018"},{"issue":"4","key":"10.1016\/j.jiac.2026.102965_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4081\/idr.2014.5646","article-title":"High prevalence of clustered tuberculosis cases in Peruvian migrants in florence, Italy","volume":"6","author":"Zammarchi","year":"2014","journal-title":"Infect Dis Rep"},{"issue":"7","key":"10.1016\/j.jiac.2026.102965_bib10","article-title":"Validation of indirect tuberculosis treatment adherence measures in a resource-constrained setting","volume":"18","author":"Mkopi","year":"2014","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2026.102965_bib11","series-title":"Correlation between medication adherence using proportion of days covered and achieving viral suppression in patients living with HIV\u2019","author":"Komandt","year":"2023"},{"key":"10.1016\/j.jiac.2026.102965_bib12","unstructured":"D. P. Nau, \u2018Proportion of days covered (PDC) as a preferred method of measuring medication adherence\u2019."},{"issue":"Aug","key":"10.1016\/j.jiac.2026.102965_bib13","article-title":"Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data","volume":"13","author":"Kwon","year":"2022","journal-title":"Front Pharmacol"},{"issue":"Mar","key":"10.1016\/j.jiac.2026.102965_bib14","article-title":"Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients","volume":"12","author":"Bea","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2026.102965_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.puhe.2024.01.021","article-title":"Predictors, mortality, and health outcomes of intensive phase non-adherence to a regimen in patients with drug-susceptible tuberculosis: a nationwide linkage database","volume":"229","author":"Lee","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.jiac.2026.102965_bib16","article-title":"The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials","author":"Vernon","year":"2019","journal-title":"Public Library of Science"},{"issue":"1","key":"10.1016\/j.jiac.2026.102965_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/ijph.ijph_1146_21","article-title":"Barriers to treatment adherence for female tuberculosis (TB) patients during the COVID-19 pandemic: qualitative evidence from front-line TB interventions in Bengaluru city, India","volume":"66","author":"George","year":"2022","journal-title":"Indian J Publ Health"},{"key":"10.1016\/j.jiac.2026.102965_bib18","series-title":"The impact of COVID-19 on tuberculosis patients' behavior of seeking medical care-China","author":"Xia","year":"2020"},{"issue":"4","key":"10.1016\/j.jiac.2026.102965_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijtb.2021.08.033","article-title":"Non-adherence to anti-tubercular treatment during COVID-19 pandemic in raipur district central India","volume":"69","author":"Jaiswal","year":"2022","journal-title":"Indian J Tubercul"},{"key":"10.1016\/j.jiac.2026.102965_bib20","series-title":"Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in northern Italy","author":"Magro","year":"2020"},{"issue":"9","key":"10.1016\/j.jiac.2026.102965_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310383","article-title":"A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in cape town, South Africa","volume":"19","author":"Jennings","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2026.102965_bib22","unstructured":"The impact of COVID-19 on the TB epidemic: a community perspective results of a global civil society and tb affected community led survey | 03 02 | the impact of covid-19 on the tb epidemic: a community perspective\u2019."},{"key":"10.1016\/j.jiac.2026.102965_bib23","article-title":"Heterogeneous effects of COVID-19 control measures on tuberculosis in South Korea: an analysis of case notification data","author":"Kim","year":"2022","journal-title":"BioMed Central Ltd"},{"key":"10.1016\/j.jiac.2026.102965_bib24","series-title":"An overview of tuberculosis and migration","author":"Dhavan","year":"2017"},{"key":"10.1016\/j.jiac.2026.102965_bib25","article-title":"Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK","author":"Hayward","year":"2018","journal-title":"NLM (Medline)"},{"key":"10.1016\/j.jiac.2026.102965_bib26","series-title":"Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature","author":"de Vries","year":"2017"},{"key":"10.1016\/j.jiac.2026.102965_bib27","series-title":"Supply interruptions of First- and second-line oral drugs to treat tuberculosis during the previous 12 months \u2014 california, january\u2013march, 2023","author":"Nabity","year":"2024"},{"issue":"7","key":"10.1016\/j.jiac.2026.102965_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015633","article-title":"The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review","volume":"9","author":"Zary","year":"2024","journal-title":"BMJ Glob Health"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:12:23Z","timestamp":1778800343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1341321X26000632"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102965","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to anti-Tuberculosis treatment during the COVID-19 pandemic: a single-centre, retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102965"}}